ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

GKOS Glaukos Corporation

108.89
1.45 (1.35%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 435,775
Bid Price
Ask Price
News -
Day High 109.6225

Low
54.3801

52 Week Range

High
113.97

Day Low 107.28
Company Name Stock Ticker Symbol Market Type
Glaukos Corporation GKOS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.45 1.35% 108.89 20:00:00
Open Price Low Price High Price Close Price Prev Close
108.09 107.28 109.6225 108.89 107.44
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,518 435,775 $ 108.54 $ 47,299,193 - 54.3801 - 113.97
Last Trade Time Type Quantity Stock Price Currency
19:00:00 52,137 $ 108.89 USD

Glaukos Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.39B 49.47M - 314.71M -134.66M -2.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Glaukos News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GKOS Message Board. Create One! See More Posts on GKOS Message Board See More Message Board Posts

Historical GKOS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week110.84110.84106.13108.63345,570-1.95-1.76%
1 Month100.28113.9795.39105.75448,9248.618.59%
3 Months88.59113.9783.9096.63484,25520.3022.91%
6 Months63.09113.9759.2288.12664,26745.8072.59%
1 Year57.89113.9754.380180.18584,08951.0088.10%
3 Years75.36113.9733.3362.24521,46533.5344.49%
5 Years64.80113.9723.3159.85534,24144.0968.04%

Glaukos Description

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Your Recent History

Delayed Upgrade Clock